Loading clinical trials...
Loading clinical trials...
A Prospective, Single-center, Randomized Controlled Trial Comparing the Functional and Oncological Outcomes of High-frequency Irreversible Electroporation and Laparoscopic Radical Prostatectomy in Men With Localized Prostate Cancer
This trial is comparing the functional and oncological outcomes in treating men with prostate cancer between high-frequency irreversible electroporation and laparoscopic radical prostatectomy.
Two hundred and sixteen patients with localized prostate cancer will include in this study. The clinical trial validation process will be as follows: (1) all patients are randomly divided into two arms: arm 1, high-frequency irreversible electroporation; group 2, laparoscopic radical prostatectomy. The primary outcome is the urinary function and sexual function.
Age
0 - 80 years
Sex
MALE
Healthy Volunteers
Yes
Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, China
Start Date
July 1, 2022
Primary Completion Date
July 1, 2026
Completion Date
September 1, 2026
Last Updated
June 2, 2022
216
ESTIMATED participants
Focal therapy(high-frequency irreversible electroporation)
PROCEDURE
laparoscopic radical prostatectomy
PROCEDURE
Lead Sponsor
Shanghai East Hospital
NCT04550494
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions